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Abstract
In skeletal muscle, pure fibres expressing one myosin heavy chain (MyHC) isoform, and
intermediate fibres, expressing two and exceptionally three MyHCs have been described.
When skeletal muscle adapts its fibre type profile to changed functional demands MyHC
isoform transformation follows the pathway: MyHC-1 ↔ MyHC-2a ↔ MyHC-2x/d ↔
MyHC-2b. Therefore, in hybrid fibres only successive isoforms from the proposed pathway
should coexist. However, jump fibres in which MyHC-1 is co-expressed with MyHC-2x/d
have been described recently. The present study describes possible coexpression of MyHC-
1 with MyHC-2b in transforming as well as in normal control mouse and rat muscle fibres.
The study is only descriptive and provides not sufficient proof to exclude the possible arte-
fact resulting from unknown technical reasons.
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An important characteristic of skeletal muscle is its
plasticity. Because of this property the muscle is able to
adapt its fibre type profile to changing physiological and
functional demands. The earliest response can be ob-
served in the changed muscle fibre metabolic profile as
well as in the capillary density. Sarcoplasmic, structural
and contractile proteins adapt by successive transforma-
tion of their protein isoforms (Salmons & Henriksson,
1981; Pette & Vrbova 1985; Pette & Staron, 1990; Pette
& Vrbova, 1992; Talmadge et al., 1995; Pette & Staron,
1997; Schiaffino & Regianni, 1996).
Myosin, the main protein responsible for muscle con-
traction, consists of heavy and light chains. Myosin
heavy chain (MyHC) isoforms are encoded by a multi-
gene family and are expressed in a tissue specific and
developmentally regulated manner (Wydro et al., 1983;
Mahdavi  et al., 1987). Skeletal muscle plasticity has
been studied extensively by myosin isoform transitions
in different experimental models.
In the skeletal muscles of small adult mammals like
mouse and rat, most fibres are pure fibres, expressing
only one MyHC isoform. However, intermediate fibres,
expressing two or more MyHC isoforms do exist in
animal and human muscles (Billeter et al., 1980; Staron
& Pette, 1986; Termin et al., 1989; Talmadge et al.;
1995; Talmadge et al., 1996; Grossman et al., 1998).
Various factors such as development, innervation, in-
creased and decreased neuromuscular activity, overload-
ing and unloading, hormones and ageing, have been
shown to influence the phenotypic expression of skeletal
muscle fibres (see Schiaffino and Reggiani, 1996; Pette
and Staron, 1997; Talmadge, 2000 for reviews).
Skeletal muscle fibre type transformations are sup-
posed to occur in a graded and orderly sequential man-
ner. MyHC isoform transitions follow the sequence go-
ing from the fastest (MyHC-2b) to the slowest (MyHC-
1) and vice versa (Mira et al., 1992; Staron & Pette,
1993; d’Albis & Butler-Browne, 1993; Pette & Staron,
1997). Muscle fibres pass through successive steps of
MyHC isoform expression. i.e. from MyHC-1 (ßslow) 
↔ MyHC-2a ↔ MyHC-2x/d ↔ MyHC-2b. During
this phase of phenotypic fibre type conversion interme-
diate fibres can be observed which contain more than
one MyHC isoform (Pierobon-Bormiolli et al., 1981;
Pette & Staron, 1990; Aigner et al., 1993; Talmadge et
al., 1995; Caiozzo et al., 1997; Grossman et al., 1998).
Therefore, the fraction of hybrid fibres could drastically
increase during processes, which promote muscle fibreMyHC-1 is co-expressed with MyHC-2b in the same fibre
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type transitions, and it was originally thought that the ap-
pearance of hybrid fibres represented a transitional state
of fibre transformation from one type to the other. How-
ever, it was subsequently demonstrated that under appro-
priate conditions hybrid fibres become increasingly more
stable and persist in large numbers for a long period of
time. One year after spinal cord transection approximately
50% of all fibres were hybrid fibres (Talmadge et al.,
1999). This suggests that under appropriate conditions
hybrid fibres may represent a “stable” phenotype.
Co-expression of MyHC-1 with MyHC-2x/d has been
described recently in so called ‘jump fibres’ (Talmadge
et al., 1995; Andersen et al., 1999b). It was confirmed
in human and rat muscles (Jacobs-El et al., 1993; Tal-
madge et al., 1995; Grossman et al., 1998; Talmadge et
al., 1999; Andersen et al., 1999a; Andersen et al.,
1999b) also by demonstrating the presence of mRNA for
both MyHC isoforms in the same muscle fibres (Jacobs-
El et al., 1993; Andersen et al., 1999a; Andersen et al.,
1999b). Co-existence of MyHC-1 with MyHC-2b has
been mentioned as a very rare event (Ståhl et al., 1994;
Snoj-Cvetko et al., 1996; Caiozzo et al., 1997), how-
ever, its presence within numerous fibres of the same
muscle has not been described yet.
The aim of the present paper was just to show that a
complete co-expression of MyHC-2b with MyHC-1 can
be obtained in some muscles, since the phenomenon was
described in gastrocnemius and tibialis anterior muscles
of one mature mouse, in extensor digitorum longus mus-
cle of two mature rats and in soleus muscle of three rats,
in which the peroneus nerve had been transposed to in-
nervate the soleus muscle. Whether both antigens really
coexist in the same muscle fibre or the immunohisto-
chemically demonstrated coexpression is artificial re-
mains an open question.
Material and Methods
Material
The animals involved in this study were primarily des-
tined for other purposes. Isolated skeletal muscles were
subsequently analysed for the unusual co-expression of
MyHC isoforms observed in control and experimental
muscles of mice and rats.
Tibialis anterior and gastrocnemius muscles of six ma-
ture untreated SWISS NMRI mice (i), extensor digitorum
longus and soleus muscles from 45 mature untreated
Wistar rats (ii), and ‘cross-innervated’ regenerating soleus
muscles of three Wistar rats (iii) were analysed. In the
latter group, the nerve normally innervating extensor
digitorum longus muscle was transected and sutured to the
distal stamp of the transected nerve of the soleus muscle
which was injected with bupivacaine (Marcaine, 0.5%;
Astra, Södertälje, Sweden), a myotoxic local anaesthetic.
Muscles were excised four months later. Soleus muscles
of nontreated animals served as a control.
All the excised muscles were frozen in liquid nitrogen
and cut into 10 µm transversal sections.
Immunohistochemistry
Muscle sections were first pretreated in a 0.1 M citrate
buffer (pH 7.2) for 5 minutes in a microwave oven and
thereafter with preimune rabbit and rat serum diluted 1/5
in phosphate buffered saline (PBS) to reduce back-
ground. Monoclonal antibodies against MyHC isoforms
MyHC-1 (BAD5), MyHC-2a (SC71), MyHC-2b (BFF3)
and MyHC-1 + MyHC-2a +MyHC-2b (negative proof
for MyHC-2x/d) (Schiaffino et al., 1986) were applied
at +4ºC overnight. Peroxidase conjugated rabbit anti
mouse IgG (Dako, Denmark) served as the secondary
antibody and the peroxidase reaction was visualised with
diaminobenzidine tetrahydrochloride.
Electrophoresis of MyHC isoforms
Muscles from normal NMRI mice were extracted on
ice for 60 minutes in 4 volumes of extracting buffer (pH
6.5) as described previously (Butler-Browne et al.,
1984). Following centrifugation, the supernatants were
diluted 1:1 (v/v) with glycerol and stored at -20°C.
MyHC isoforms were separated on 8% polyacrylamide
gels which were made in the Bio-Rad mini-Protean II
dual slab cell system as described previously (Agbulut et
al., 1996). Proteins migrated for 31 hours at 72 V (con-
stant voltage) at 4°C. Following migration, the gels were
silver-stained according to Blum et al. (1987).
Western-blot of MyHC isoforms
For western blot analysis, the gels were prepared un-
der the same conditions as above. The proteins were
transferred onto nitro-cellulose membranes by active
transfer overnight at 30 V (constant voltage). Following
transfer, the nitro-cellulose membranes were blocked to
eliminate non-specific binding in 3% foetal calf serum
diluted in PBS. The blots were then incubated with the
primary antibodies BF-F3 (Schiaffino et al., 1986),
(1/20) and BA-D5 (1/10) (Schiaffino et al., 1986). The
biotin labelled secondary antibody was applied for 45
minutes at room temperature (Dako, Copenhagen, Den-
mark), followed by the streptavidin biotin HRP complex
(Dako, Copenhagen, Denmark). Specific antibody
binding was visualised by incubating the membranes in
the diaminobenzidine substrate mixture until the bands
were sufficiently intense. The reaction was stopped by
washing the membranes in tap water.
Results
Immunohistochemistry
In the mouse tibialis anterior (TA) and gastrocnemius
(GCM) and the rat extensor digitorum longus muscles
immunoperoxidase staining of MyHC isoforms in mus-
cle fibre cross-sections is presented in Figures 1, 2 and
3. One out of the six mice (Figures 1 and 2) and two outMyHC-1 is co-expressed with MyHC-2b in the same fibre
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of 45 mature rats (Figure 3) showed unusual expression
of MyHC isoforms. In the control mouse all fibres that
showed positive staining after binding specific antibody
against MyHC-2b (BFF3) (Figures 1c, 2d) exhibited an
intense staining after binding BAD5, the antibody spe-
cific for MyHC-1 isoform (Figures 1a, 2a). In the con-
trol rat, all fibres that expressed MyHC-2b (Figure 3d)
exhibited an intermediate staining intensity after binding
BAD5 (Figure 3a). Pure type 1 fibres exhibited very
dark staining. In the mouse, estimated area percentage of
hybrid MyHC-1/MyHC-2b expressing fibres was about
15% in tibialis anterior and about 50 to 60% in gastroc-
nemius muscle. The rest of the fibres in the TA con-
tained MyHC-1, MyHC-2a, MyHC-2a/MyHC-2x/d or
MyHC-2x/d. In GCM MyHC-1, MyHC-2a/ MyHC-1
and MyHC-2a/2x/d expressing fibres were identified. In
the remaining five mice, no co-expression of MyHC-1
with MyHC-2b was found, neither in the TA nor in the
GCM muscle (Figures 1e, 1f, 2c, 2f).
In the both rat EDL muscles with unusual MyHC iso-
form expression the area percentage of hybrid fibres was
45%. No co-expression of MyHC-1 with MyHC-2b was
found in about 43 rat muscles, which served as a control
in other experiments (Figures 3c, 3f).
Cross-innervated regenerated rat soleus muscles exhib-
ited different levels of staining intensity after binding of
BFF3 antibody (MyHC-2b): very strong in one rat (Figure
4g) and less intense in the other two rats (Figures 4b, 4l).
However, in all three rats, there was an evident co-
expression of MyHC-2b with MyHC-1: many fibers were
stained by both BFF3 and BAD5 antibodies on serial sec-
tions, respectively. Estimated area percentage of hybrid
fibres was about 30%. Control sections, where primary
antibody was omitted, showed no background staining
(Figure 4o). In nontreated control animals, MyHC-2b
(Figure 4j) and MyHC-2x/d could not be detected in their
soleus muscle fibers (figure not shown). The majority of
Figure 1. Immunoperoxidase staining in the mouse tibi-
alis anterior muscle (the mouse with unusual im-
munohistochemical characteristics (a-d) and a
control mouse (e, f)) after binding of monoclonal
antibodies BAD5 (a, e), BFF3 (c, f), SC71 (b)
and BF35 (d) to demonstrate MyHC isoforms
MyHC-1 (a, e), MyHC-2b (c, f), MyHC-2a (b)
and MyHC-2x/d (d). Scale bar is 100µm.
Figure 2. Immunoperoxidase staining in the mouse gas-
trocnemius muscle (the mouse with unusual im-
munohistochemical characteristics (a, b, d, e)
and a control mouse (c, f)) after binding of
monoclonal antibodies BAD5 (a, c), BFF3 (d, f),
SC71 (b) and BF35 (e) to demonstrate MyHC
isoforms MyHC-1 (a, c), MyHC-2b (d, f), MyHC-
2a (b) and MyHC-2x/d (e). Scale bar is100µm.
Figure 3. Immunoperoxidase staining in the rat extensor
digitorum longus muscle (the  rat with unusual
immunohistochemical characteristics (a, b, d, e)
and a control rat (c, f)) after binding of mono-
clonal antibodies BAD5 (a, c), BFF3 (d, f), SC71
(b) and BF35 (e) to demonstrate MyHC isoforms
MyHC-1 (a, c), MyHC-2b (d, f), MyHC-2a (b)
and MyHC-2x/d (e). Scale bar is100µm.MyHC-1 is co-expressed with MyHC-2b in the same fibre
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Figure 4. Immunoperoxidase staining after binding of monoclonal antibodies BAD5 (a, f, k), BFF3 (b, g, l), SC71 (c, h, m)
and BF35 (d, i, n) to demonstrate MyHC isoforms MyHC-1 (a, f, k), MyHC-2b (b, g, l), MyHC-2a (c, h, m) and
MyHC-2x/d (d, i, n) in regenerated cross-innervated soleus muscles of three experimental rats (after bupivacaine
injection and transposition of the ‘EDL’ nerve). The soleus muscle of the control rat is stained for MyHC-1 (e) and
MyHC-2b (j). Control section, incubated without the primary antibody is shown in panel (o). Scale bar is 500µm.MyHC-1 is co-expressed with MyHC-2b in the same fibre
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the fibres contained MyHC-1 (Figure 4e) and only a few
fibres MyHC-2a (not shown).
Electrophoresis and immunoblotting
Specificity of antibodies directed against MyHC-2b
(Figure 5a) and MyHC-1 (Figure 5c) was demonstrated
by immunoblotting of corresponding gels, where MyHC
isoforms had been separated by SDS glycerol gel elec-
trophoresis (Figures 5b, 5d).
Discussion
Based on immunohistochemical reactions with mono-
clonal antibodies whose specificity for binding to par-
ticular myosin heavy chain isoforms was proved elec-
trophoretically, the present report points to the possibil-
ity that in addition to the recently described co-
expression of MyHC-1 with MyHC-2x/d in jump fibres
(Talmadge et al., 1995; Andersen, et al. 1999b), MyHC-
1 can also be co-expressed with MyHC-2b in hybrid fi-
bres. To unequivocally prove this statement additionally
the presence of transcripts of both isoforms should have
been demonstrated and co-existence of both isoforms
should be  proved within the same fibre using electro-
phoresis. Since the material described in this study was
used for other purposes and the phenomenon of co-
expression was noticed only later additional analysis of
the material is not possible.
Although indications of the possible co-expression of
MyHC-1 with MyHC-2b have been mentioned in the
literature (Ståhl et al., 1994; Snoj-Cvetko et al., 1996;
Caiozzo et al., 1997) in contrast to this study, coexis-
tence of both MyHC isoforms was described only in in-
dividual muscle fibres and the phenomenon has not been
generally accepted.
We were well aware that the observed MyHC-2b and
MyHC-1 co-expression in a high percentage of muscle
fibres is very unusual. Therefore, we carefully checked
possibilities that might lead to an artificial co-
localisation of both MyHC isoforms in the same muscle
fibres of the samples analysed in this study. (i) The re-
sults obtained in this study proved to be reproducible
since equal results were obtained on the same material in
three independent immunoperoxidase stainings.
(ii)Immunoperoxidase reaction was clear with no back-
ground staining and control sections were completely
unstained (Figure 3).
(iii) The observed MyHC isoform co-expression is
most probably not due to the lack of antibody specific-
ity. By using SDS glycerol gel electrophoresis and im-
munoblotting in parallel experiments, we have proved
that BFF3 antibody specifically binds to MyHC-2b and
BAD5 antibody to MyHC-1, from both rat and mouse
muscles (Figure 3). However, this does not exclude a
possible cross-reaction with another unknown antigen
that might be present in some muscles in fibres ex-
pressing MyHC-1.
(iv) The BFF3 antibody, as described by Schiaffino
et al. (1989) is an IgM, in contrast to the other anti-
bodies, which are all IgGs. This is probably the reason
why the staining intensity is weaker after immunoper-
oxidase detection with this antibody compared to the
reaction obtained after binding of antibodies against
other MyHC isoforms.
In the present study possible co-expression of MyHC-1
with MyHC-2b has been found even in mature muscles of
mouse and rat, what indicates that the described pheno-
type can be stable. However, in general it is a rare event.
In regenerating cross-innervated rat soleus muscles,
all muscle fibres that showed positive immunohisto-
chemical reaction after binding of the monoclonal an-
tibody against MyHC-2b, also co-expressed MyHC-1.
However, the immunohistochemically estimated level
of MyHC-2b was different in different animals sug-
gesting that the observed MyHC co-expression in ex-
perimental rats was probably only transient. In agree-
ment with this, in our further experiments (results not
shown) where we analysed Marcaine injected soleus
muscles five months after peroneal nerve transposition,
there was not a trace of the co-expression of MHC-1
with MHC-2b. This is also reinforced by the recent
data of Agbulut et al. (personal communication, manu-
script in preparation) who have showed by SDS glyc-
erol gel electrophoresis that MHC-2b is transiently ex-
pressed in the soleus muscle both during development
and regeneration of the soleus muscle.
Intermediate fibres, expressing two or more MyHC iso-
forms have been described in animal and human muscles
(Billeter  et al., 1980; Pierobon-Bormiolli et al., 1981;
Pette & Staron, 1990; Aigner et al., 1993; Talmadge et
al., 1995; Sant’Ana Pereira et al., 1995; Andersen &
Schiaffino, 1997; Caiozzo et al., 1997; Grossman et al.,
1998). The question as to whether the intermediate fibres
represent transitional fibres, resulting from transformation
of one fibre into another, or represent a stable fibre type
with a mixed myosin composition, has been addressed in
Figure 5. Electrophoretic separation (b, d) and western
blot analysis (a, c) of MyHC isoforms of mouse
soleus, diaphragm and gastrocnemius muscles
after binding of monoclonal antibodies BFF3 (a)
BAD5 (c) to confirm the specificity of these anti-
bodies for MyHC-2b (a) and MyHC-1 (c). SOL -
soleus, DIA - diaphragm, GAS - gastrocnemius.MyHC-1 is co-expressed with MyHC-2b in the same fibre
- 124 -
different studies (Talmadge et al., 1995; Andersen &
Schiaffino, 1997; Talmadge, 2000). In muscles, exposed
to experimental procedures that promoted fast to slow or
slow to fast fibre type transitions, some fibres have been
demonstrated to express two MyHC isoforms for a long
time after the original experimental trigger had ceased
(Talmadge et al., 1999). Therefore, one can assume that
intermediate fibres probably represent a stable fibre type
(Talmadge, 2000).
Existence of ‘jump fibres’ in experimentally modified
muscles indicates that MyHC isoform transitions may not
always follow the pathway from MyHC-1 (ßslow) ↔
MyHC-2a ↔MyHC-2x/d ↔MyHC-2b and vice versa.
When a muscle has to adapt quickly to a new physiologi-
cal or experimentally induced conditions, protein tran-
scription might skip one or two MyHC encoding
genes, resulting in the co-expression of MyHC-1 with
MyHC-2x/d (without MyHC-2a)  (Talmadge  et al.,
1995; Andersen & Schiaffino, 1997; Grossman et al.,
1998; Andersen, et al. 1999b) or turn over times of
these intermediate MHC isoforms may vary. However,
in animal muscles the induced percentage of jump fi-
bres was much higher than that in human muscles
(Talmadge et al., 1995; Grossman et al., 1998; Ander-
sen et al., 1999b).
Myonuclear discoordination in mRNA expression could
result from the fact that some myonuclei might be pre-
programmed to maintain a slow phenotype, or they might
be more resistant to adaptation than other myonuclei. On
the other hand, each myonucleus may transcribe multiple
MyHC genes more or less simultaneously. In 30-day spi-
nal cord transected rat soleus, 40% of the fibres co-
express MyHC-1 with MyHC-2x/d and a similar phe-
nomenon has been described after space flight (Talmadge
et al., 1995; Grossman et al., 1998). These findings dem-
onstrate that at least some fibres or myonuclei have the
ability to ‘jump’ from type MyHC-1 to type MyHC-2x/d
expression rapidly and perhaps without first expressing
type MyHC-2a. Hence, slow to fast transformation in the
rat soleus does not necessarily have to occur through a
sequential conversion from type 1 ￿ 2a ￿ 2x/d ￿ 2b.
The present study suggests the possibility that muscle
fibre transformations can be even faster and two isoforms
can be skipped. Persistence of this unusual phenotype
even in mature control animals, in which no experimental
procedure that promotes fibre type transformation was
induced, is difficult to explain. If every myonucleus has an
equal chance to express all MyHC isoforms then intrinsic
and extrinsic factors might be those that favour expression
of one or the other gene. For the maintenance of expres-
sion of a single MyHC isoform, such as that normally ob-
served in control fast and slow hindlimb muscles either
proper electrical activation or load bearing or both are re-
quired (Talmadge, 2000).
In summary, we have found that the co-expression of
MyHC-1 with MyHC-2b can occur not only within single
fibres in different muscles but also in the majority of fi-
bres in muscles of a mature mouse and rat and in muscle
samples of some experimental rats. However, the methods
that we have used could not provide sufficient proof for
an unequivocal coexistence of both antigens within the
same muscle fibre. Subsequently they did not allow us to
give any reliable explanation of the mechanism underlying
this unusual co-expression of MyHC isoforms in mice and
rats, therefore we leave this question open.
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